Evidence map›Paper›PMID 29587685›Full record

ArticleBMC cancer2018

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.

Yasuko Nagamatsu, Isao Oze, Keisuke Aoe, Katsuyuki Hotta, Katsuya Kato, Junko Nakagawa, Keiko Hara, Takumi Kishimoto, Nobukazu Fujimoto

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06491784 (EXercise TheRApy in Mesothelioma - A Feasibility Study), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06491784 naunknown statusnot on this mapstarted 2024, after this paper: background citation

EXercise TheRApy in Mesothelioma - A Feasibility Study

TypeinterventionalSponsorNHS Greater Glasgow and ClydeRan2024 to 2025Enrolled40ConditionsMesotheliomaArmsExercise Therapy
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Yasuko NagamatsuGraduate School of Nursing Science, St. Luke's International University, 10-1 Akashicho, Chuo-ku, Tokyo, 1040044, Japan.
Isao OzeDivision of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chigusa-ku, Nagoya, 4648681, Japan.
Keisuke AoeNational Hospital Organization Yamaguchi-Ube Medical Center, Department of Medical Oncology, 685 Higashikiwa, Ube, 7550241, Japan.
Katsuyuki HottaCenter for Innovative Clinical Medicine, Okayama University Hospital, 2-5-1 Shikatacho, Okayama, 7008558, Japan.
Katsuya KatoDepartment of Radiology, Kawasaki General Medical Center, 2-6-1 Nakasange, Okayama, 7008505, Japan.
Junko NakagawaDepartment of Nursing, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Okayama, 7028055, Japan.
Keiko HaraDepartment of Nursing, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Okayama, 7028055, Japan.
Takumi KishimotoDepartment of Medicine, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Okayama, 7028055, Japan.
Nobukazu FujimotoDepartment of Medical Oncology, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Okayama, 7028055, Japan. nobufujimot@gmail.com.ORCID 0000-0002-4516-0433
Okayama Rosai Hospital · JPAichi Cancer Center · JPKawasaki Medical School · JPNational Sanyo Hospital · JPOkayama University Hospital · JPSt. Luke's International University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have indicated that people with malignant pleural mesothelioma (MPM) have a poor quality of life (QOL); however, information about the QOL of people with MPM in Japan is anecdotal. The aims of this study were to investigate the QOL of survivors of MPM in Japan and to determine the factors that correlate with their QOL.

methodsThis was a cross sectional study. The included patients were those diagnosed with MPM in Japan. We created a self-administered questionnaire consisting of 64 questions. The questionnaires were sent to hospitals and patient advocacy groups, distributed to the patients, completed, and sent back to the researchers by postal mail. QOL was assessed with the European Organization for Research and Treatment of Cancer 16 questionnaire (QLQ) and the short version of the core domains of the Comprehensive Quality of Life Outcome questionnaire (CoQoLo).

resultsIn total, 133 questionnaires were collected. The QLQ assessments demonstrated that the survivors of MPM most frequently complained of fatigue, pain, sleep disturbances, and dyspnea. The symptom scales were acceptable, but the functional scales were significantly poorer for the patients with poor performance statuses (PSs). The short CoQoLo assessment was very unfavorable for 'Being free from physical pain.' Being a long-term survivor and a survivor with a poor PS were significantly correlated with poor global health status.

conclusionsSurvivors of MPM have impaired function, a variety of symptoms, and lower QOL. Survivors of MPM, even those in good physical condition, need broad support.

Indexed as

Quality of LifeSurvivorsAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansJapanLung NeoplasmsMaleMesotheliomaMesothelioma, MalignantMiddle AgedPalliative CarePleural NeoplasmsAsbestosCoQoLoMesotheliomaPalliative careQuality of lifeQuestionnaire

Identifiers

PMID29587685
PMCPMC5872515
OpenAlexW2800041050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.